SNCA, a novel biomarker for Group 4 medulloblastomas, can inhibit tumor invasion and induce apoptosis

In conclusion, we identify SNCA as a novel diagnostic biomarker for Group 4 medulloblastoma. Some other subgroup signature genes have also been found as candidate therapeutic targets for this tumor.
This article is protected by copyright. All rights reserved.

Source: Cancer Science - January 1, 2018 Category: Cancer & Oncology Authors: Yong ‐Xiao Li, Zhen‐Wei Yu, Tao Jiang, Li‐Wei Shao, Yan Liu, Na Li, Yu‐Feng Wu, Chen Zheng, Xiao‐Yu Wu, Ming Zhang, Dan‐Feng Zheng, Xue‐Ling Qi, Min Ding, Jing Zhang, Qing Chang Tags: Original Article Source Type: research